|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4192 | (2006.01) |
| A61P 35/02 | (2006.01) | ||
| C07C 237/22 | (2006.01) | ||
| C07C 211/35 | (2006.01) | ||
| C07D 249/06 | (2006.01) |
| (11) | Number of the document | 3256218 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16749986.2 |
| Date of filing the European patent application | 2016-02-12 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-11 |
| (46) | Date of publication of the claims translation | 2025-02-10 |
| (86) | Number | PCT/US2016/017809 |
| Date | 2016-02-12 |
| (87) | Number | WO 2016/130952 |
| Date | 2016-08-18 |
| (30) | Number | Date | Country code |
| 201562115474 P | 2015-02-12 | US |
| (72) |
RIENHOFF, Hugh Young Jr. , US
MCCALL, John M. , US
CLARE, Michael , US
CELATKA, Cassandra , US
TAPPER, Amy E. , US
|
| (73) |
Imago Biosciences Inc. ,
2729 Debbie Court, San Carlos, CA 94070,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | KDM1A inhibitorius ir jo panaudojimas terapijoje |
| A KDM1A INHIBITOR AND ITS USE IN THERAPY |
| Payment date | Validity (years) | Amount | |
| 2024-12-17 | 10 | 231.00 EUR |
| 2026-02-12 |